*ST Jingfeng: The restructuring plan will issue 10 additional shares for every 10 shares held

*ST Jingfeng announces that the restructuring plan will be based on Jingfeng Pharmaceutical’s current share capital of 880 million shares, with a capital reserve conversion ratio of 10 shares for every 10 shares transferred. A total of 880 million shares can be converted. After the transfer, Jingfeng Pharmaceutical’s total share capital will increase to 1.76 billion shares. The 880 million shares transferred will no longer be distributed to the original shareholders, and will be fully used to introduce restructuring investors. The restructuring investors will provide funds to subscribe, and the corresponding funds will be used to pay bankruptcy expenses, settle various debts, and supplement the company’s working capital in accordance with the provisions of the restructuring plan.